EN
Adaptive Phage Therapy in the Treatment of Patients with Recurrent Pneumonia (Pilot Study)
On the effectiveness and safety of adaptive phage therapy technology in neurological critical care.
MICROMIR
As a result of a clinical study conducted jointly by the teams of the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology of the Ministry of Science and Higher Education of the Russian Federation (FRCC ICMR) and RPC Micromir in the intensive care units of the FRCC ICMR, the first experience of using adaptive phage therapy technology in neurological critical care was obtained.
You are welcome to cite the materials, but be sure to provide an active link to the site. Thank you!
As a result of a clinical study conducted jointly by the teams of the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology of the Ministry of Science and Higher Education of the Russian Federation (FRCC ICMR) and RPC Micromir in the intensive care units of the FRCC ICMR, the first experience of using adaptive phage therapy technology in neurological critical care was obtained.
You are welcome to cite the materials, but be sure to provide an active link to the site. Thank you!
The first experience of using the adaptive phage therapy technique in chronically critically ill patients in neurological intensive care demonstrated the safety of inhalational administration of the bacteriophage cocktail.
The efficacy of the technique was confirmed by the treatment results obtained in the phage therapy group, which were not inferior to those in the group with conventional antibiotic therapy, while several clinical and laboratory parameters tended to improve even in patients who received bacteriophages and did not receive antibiotics.
The results of our study are presented in an article for the General Reanimatology Journal.
The authors of the article are N.V. Beloborodova, A.V. Grechko, M.M. Gurkova, A.Yu. Zurabov, F.M. Zurabov, A.N. Kuzovlev, A.Yu. Meglei, M.V. Petrova, V.M. Popova, I.V. Redkin, N.I. Sergeev, E.A. Chernevskaya, M.Yu. Yuriev, A.A. Yakovlev.
The efficacy of the technique was confirmed by the treatment results obtained in the phage therapy group, which were not inferior to those in the group with conventional antibiotic therapy, while several clinical and laboratory parameters tended to improve even in patients who received bacteriophages and did not receive antibiotics.
The results of our study are presented in an article for the General Reanimatology Journal.
The authors of the article are N.V. Beloborodova, A.V. Grechko, M.M. Gurkova, A.Yu. Zurabov, F.M. Zurabov, A.N. Kuzovlev, A.Yu. Meglei, M.V. Petrova, V.M. Popova, I.V. Redkin, N.I. Sergeev, E.A. Chernevskaya, M.Yu. Yuriev, A.A. Yakovlev.
Other materials
We write about phage therapy, bacteriophages and their applications, as well as about modern science and Micromir's inner workings.
Any questions?
Contact Us
Phone: +7 (495) 625-32-65
Mail: office@micromir.bio
Mail: office@micromir.bio
© RPC «Micromir»
Veterinary
By using this website, you agree to the use of cookies. We use cookies to provide you with a great experience and to help the website run effectively. More information...
OK